KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $47.7 billion.

  • Thermo Fisher Scientific's Total Non-Current Liabilities rose 1.42% to $47.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $47.7 billion, marking a year-over-year increase of 1.42%. This contributed to the annual value of $43.7 billion for FY2024, which is 7.61% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Total Non-Current Liabilities of $47.7 billion as of Q3 2025, which was up 2.73% from $46.4 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Total Non-Current Liabilities' 5-year high stood at $49.7 billion during Q4 2021, with a 5-year trough of $27.3 billion in Q3 2021.
  • For the 3-year period, Thermo Fisher Scientific's Total Non-Current Liabilities averaged around $46.7 billion, with its median value being $47.0 billion (2024).
  • As far as peak fluctuations go, Thermo Fisher Scientific's Total Non-Current Liabilities spiked by 71.01% in 2022, and later dropped by 7.61% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Total Non-Current Liabilities (Quarterly) stood at $49.7 billion in 2021, then dropped by 1.70% to $48.9 billion in 2022, then fell by 3.14% to $47.3 billion in 2023, then declined by 7.61% to $43.7 billion in 2024, then climbed by 1.42% to $47.7 billion in 2025.
  • Its Total Non-Current Liabilities was $47.7 billion in Q3 2025, compared to $46.4 billion in Q2 2025 and $45.7 billion in Q1 2025.